Author

J. Huling

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

N. L. Allbritton· 2 shared Y. Wang· 2 shared B. P. Keith· 1 shared C. A. DeForest· 1 shared C. Beasley· 1 shared E. A. Wolber· 1 shared H. Wang· 1 shared J. Barrow· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

N. L. Allbritton

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Magnetically-Propelled Fecal Surrogates for Modeling the Impact of Solid-Induced Shear Forces on Primary Colonic Epithelial Cells

S. S. Hinman, J. Huling, Y. Wang, H. Wang, R. C. Bretherton, C. A. DeForest, N. L. Allbritton

This paper develops magnetically propelled fecal surrogates to study the impact of solid-induced shear forces on colonic epithelial cells, finding that these forces modulate mucus production and cytokine secretion without harming cell viability.

bioRxiv · Feb 18, 2021Bioengineering

Decreased Colonic Activin Receptor Like Kinase 1 Disrupts Epithelial Barrier integrity and is associated with a poor clinical outcome in Crohns disease

T. Toyonaga, B. P. Keith, J. Barrow, M. S. Schaner, E. A. Wolber, C. Beasley, J. Huling, Y. Wang, N. L. Allbritton, N. Chaumont, T. S. Sadiq, M. J. Koruda, R. Rahbar, T. S. Furey, P. Sethupathy, S. Z. Sheikh

This study identifies ALK1 as a target of miR-31-5p in CD, showing that decreased ALK1 disrupts epithelial barrier integrity and correlates with poor clinical outcomes.

bioRxiv · Feb 21, 2020Cell Biology